North America wound care biologics market is expected to grow with a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases, rising number of geriatric population, innovation in wound care biologics are fuel the growth of wound care biologics market.

The key market players for North America wound care biologics market are listed below;

Integra LifeSciences
ConvaTec Inc.
AlloSource
Amniox Medical, Inc.
Marine Polymer Technologies, Inc.
Solsys Medical
ACell Inc.
Kerecis
WRIGHT MEDICAL GROUP N.V.
Vericel Corporation
Anika Therapeutics, Inc.
Skye Biologics Inc.
BioHorizons IPH, Inc
Alphatec Spine, Inc.
Amnio Technology, LLC
M?lnlycke Health Care AB
Smith and Nephew
MiMedx
Organogenesis Inc.
Osiris Therapeutics, Inc.

The North America wound care biologics market is segmented into;
Product Type
Wound Type
End User
?
On the basis of product type the North America wound care biologics market is segmented into synthetic skin grafts segment, growth factors segment, allografts segment, xenografts segment. In 2018, synthetic skin grafts segment is expected to dominate the North America wound care biologics market with highest market shares. However, allografts segment is expected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF) segment, platelet rich plasma (PRP) segment, epidermal growth factor (EGF) segment and basic fibroblast growth factor (BFGF) segment, granulocyte colony stimulating factor (G-CSF), talactoferrin alfa segment, thrombin peptide (TP508) segment, keratinocyte growth factor (KGF) segment.
On the basis of wound type the North America wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segment is expected to dominate the North America wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.
On the basis of end user North America wound care biologics market is segmented into hospitals, wound care centres and ambulatory centres, clinics, community healthcare centers. In 2018, hospitals are expected to dominate the North America wound care biologics market with the highest CAGR in the forecast period 2018 to 2025.
Based on geography, the market is segmented into 3 geographical regions;
U.S.
Canada
Mexico
Covered in this report
The report covers the present scenario and the growth prospects of the North America wound care biologics market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.